Continuing Medical Education
Practicing ophthalmologists who care for patients with corneal-related conditions.
At the conclusion of this program, attendees will be able to:
- Integrate crosslinking into practice
- Compare and contrast modalities for ocular surface reconstruction
- Implement strategies to identify and efficiently manage patients with ocular surface disease/dry eye disease preoperatively
- Compare and contrast new advances in dry eye disease
- Incorporate methods and pearls to successfully perform anterior segment surgery with concurrent corneal disease
- Implement strategies to transition from DSAEK to DMEK
- Analyze the indications and surgical techniques for newer forms of lamellar keratoplasty
- Assess corneas from expanded donor pool
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and the Cornea Society. ASCRS is accredited by the ACCME to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of this CME activity.
The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.
All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME).
Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits.
Note: All attendees must print their badges onsite to verify attendance for CME eligibility. The program evaluation and CME credit claim will be available online.
Notice of Off-Label Use Presentations
This program may include presentations on drugs or devices, or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.
ASCRS fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any registrant who requires special accommodation should contact the ASCRS•ASOA Meetings Department by April 17, 2016: (703) 591-2220.